Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Prohibitions Against Discriminatory Practices relating to 340B Entities and 340B Drugs; Prohibits drug manufacturers from engaging in certain acts against acquisitions of 340B drugs by & delivery of such drugs to specified pharmacies & from interfering with pharmacies' rights to contract with 340B entities; prohibits health insurance issuers, PBMs & other third-party payors, & agents, from engaging in discriminatory acts relating to reimbursement to 340B entities for 340B drugs; prohibits health insurers & HMOs from engaging in discriminatory acts relating to reimbursement to 340B entities for 340B drugs; provides that each commission of certain acts constitutes violation of Florida Deceptive & Unfair Trade Practices Act & subjects violator to certain actions & penalties.
Introduced
Jan 13, 2026
Last Action
Jan 15, 2026
Session
FL 2026
Sponsors
1 primary · 0 co
Referred to Health Care Facilities & Systems Subcommittee
Referred to Insurance & Banking Subcommittee
Referred to Health & Human Services Committee
Now in Health Care Facilities & Systems Subcommittee
1st Reading (Original Filed Version)
Filed
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
Now in Health Care Facilities & Systems Subcommittee